Results 181 to 190 of about 101,493 (261)

Browsing FAIR Transformation Product Information with FAIR-TPs. [PDF]

open access: yesACS Environ Au
Mayahi B, Palm EH, Schymanski EL.
europepmc   +1 more source

What exploitation is

open access: yesAmerican Journal of Political Science, EarlyView.
Abstract We experimentally elicit views of what exploitation is from over 2,000 subjects. Our experimental design does not test existing theories of exploitation. Rather, it focuses on more fundamental properties that are the building blocks for these theories.
Benjamin Ferguson   +3 more
wiley   +1 more source

Prehospital whole-blood transfusion in two countries: comparison of patient characteristics in Sweden and the Northeastern United States. [PDF]

open access: yesEur J Trauma Emerg Surg
Backstrom D   +8 more
europepmc   +1 more source

The relation between clinical response and quality of life improvement after treatment with intravenous methylprednisolone in Graves' orbitopathy

open access: yesActa Ophthalmologica, EarlyView.
Abstract Background Quality of life (QoL) is a key outcome in Graves' orbitopathy (GO), but prior studies have reported overall QoL changes without evaluating whether improvements occur specifically in patients who achieve objective clinical response.
Gijsbert J. Hötte   +8 more
wiley   +1 more source

Variation in Stabilization and Resuscitation Practices at Birth of Preterm Infants Among 12 National or Regional Neonatal Networks

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Neonatal resuscitation follows national or regional guidelines, but uptake varies in clinical practice. This study aimed to examine variations in reported delivery room practices for infants < 29 weeks' gestation across neonatal units in 12 networks of the International Network for Evaluating Outcomes in Neonates.
Maria Fernanda de Almeida   +676 more
wiley   +1 more source

Norman L Jones Award

open access: yesCanadian Respiratory Journal, 2014
doaj   +1 more source

Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress?

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Individualized assessment identifies patients with decompensated autoimmune hepatitis cirrhosis who are likely to benefit from a time‐limited trial of immunosuppression versus those requiring immediate liver transplant evaluation. Early objective response monitoring (bilirubin, MELD‐Na and AST/ALT) guides continuation of immunosuppression, promotes ...
Pedro Robson Costa Passos   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy